Stay updated on Long-Term Upadacitinib in Crohn's Disease Clinical Trial
Sign up to get notified when there's something new on the Long-Term Upadacitinib in Crohn's Disease Clinical Trial page.

Latest updates to the Long-Term Upadacitinib in Crohn's Disease Clinical Trial page
- Check4 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1; the page remains a 403 error screen.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe study record URL now serves a 403 Forbidden page, indicating access to the content is blocked; the error page includes the site header and navigation.SummaryDifference20%

- Check46 days agoChange DetectedAdded funding disclosure: 2015 ( U.S. NIH Grant/Contract ) under Other Study ID Numbers. Updated the page revision from v3.6.5 to v3.6.6 to reflect the current version.SummaryDifference0.1%

- Check60 days agoChange DetectedNew clinical sites were added (Manchester, Oslo, Hradec Kralové, Liege, Madrid, etc.) and several existing locations were removed or reformatted, signaling an update to the study's site list. The update also adds a 'Results Posted' entry and new Month 12-related outcome details, reflecting updated results reporting and timepoints for the study.SummaryDifference5%

- Check67 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing v3.6.4, indicating a small update to the page's version history. This change does not alter the study details or data presented on the page.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, signaling a minor update to the page's underlying version.SummaryDifference0.0%

Stay in the know with updates to Long-Term Upadacitinib in Crohn's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Upadacitinib in Crohn's Disease Clinical Trial page.